Wei W Z, Massey R J, Heppner G H
Cancer Immunol Immunother. 1985;20(2):137-44. doi: 10.1007/BF00205680.
A 3-dimensional tumor growth inhibition assay [18] has been adapted to test the cytotoxic activity of a panel of monoclonal antibodies directed to various antigenic determinants on the surface of mouse mammary tumor cells. Target cells can be prepared from either cultured cells or from pieces of fresh tumor. Antibody and complement are added when cells are growing actively and cell growth can be measured, non destructively, over a 7-10-day period. Effective diffusion of antibody through collagen gel and binding to target cells embedded in the gel is demonstrated by indirect immunofluorescent staining. The specificity of monoclonal antibody AMT 101 cytotoxicity for mouse mammary tumor cells is the same in trypan blue exclusion assays of single-cell suspensions as in collagen gel assays, with complete killing seen in the collagen gel assay only. The collagen gel assay allows the testing of repeated treatments in vitro, as well as combined treatment with multiple antibodies. It also allows cell-cell interaction and preserves all cell components in the tumor. The collagen gel assay has potential as a method of predicting the outcome of monoclonal antibody treatment of solid tumors.
一种三维肿瘤生长抑制试验[18]已被改编用于测试一组针对小鼠乳腺肿瘤细胞表面各种抗原决定簇的单克隆抗体的细胞毒性活性。靶细胞可以从培养细胞或新鲜肿瘤组织中制备。当细胞活跃生长时添加抗体和补体,并且可以在7至10天的时间内无损测量细胞生长。通过间接免疫荧光染色证明抗体通过胶原凝胶的有效扩散以及与包埋在凝胶中的靶细胞的结合。在单细胞悬液的台盼蓝排斥试验中,单克隆抗体AMT 101对小鼠乳腺肿瘤细胞的细胞毒性特异性与在胶原凝胶试验中相同,仅在胶原凝胶试验中观察到完全杀伤。胶原凝胶试验允许在体外测试重复治疗以及多种抗体的联合治疗。它还允许细胞间相互作用并保留肿瘤中的所有细胞成分。胶原凝胶试验有潜力作为预测实体瘤单克隆抗体治疗结果的一种方法。